Clorox Co (NYSE:CLX) COO Dawn C. Willoughby sold 54,205 shares of the business’s stock in a transaction dated Tuesday, November 6th. The stock was sold at an average price of $157.39, for a total transaction of $8,531,324.95. Following the completion of the sale, the chief operating officer now owns 37,044 shares in the company, valued at $5,830,355.16. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link.

Dawn C. Willoughby also recently made the following trade(s):

  • On Wednesday, September 5th, Dawn C. Willoughby sold 3,387 shares of Clorox stock. The stock was sold at an average price of $148.01, for a total transaction of $501,309.87.

Shares of CLX stock opened at $158.77 on Friday. Clorox Co has a twelve month low of $113.57 and a twelve month high of $159.17. The stock has a market capitalization of $20.25 billion, a P/E ratio of 25.36, a PEG ratio of 3.89 and a beta of 0.28. The company has a debt-to-equity ratio of 3.38, a current ratio of 1.07 and a quick ratio of 0.65.

Clorox (NYSE:CLX) last announced its earnings results on Wednesday, October 31st. The company reported $1.62 earnings per share for the quarter, beating the consensus estimate of $1.59 by $0.03. Clorox had a net margin of 13.59% and a return on equity of 102.65%. The firm had revenue of $1.56 billion during the quarter, compared to the consensus estimate of $1.53 billion. During the same quarter in the previous year, the company posted $1.46 EPS. The firm’s revenue for the quarter was up 4.2% on a year-over-year basis. On average, analysts expect that Clorox Co will post 6.31 EPS for the current year.

The company also recently announced a quarterly dividend, which will be paid on Friday, November 16th. Investors of record on Wednesday, October 31st will be paid a $0.96 dividend. This represents a $3.84 annualized dividend and a yield of 2.42%. The ex-dividend date of this dividend is Tuesday, October 30th. Clorox’s payout ratio is 61.34%.

A number of hedge funds have recently made changes to their positions in CLX. Millennium Management LLC increased its stake in shares of Clorox by 539.2% during the 1st quarter. Millennium Management LLC now owns 63,727 shares of the company’s stock valued at $8,483,000 after acquiring an additional 53,757 shares during the last quarter. Allianz Asset Management GmbH increased its stake in shares of Clorox by 7.3% during the 1st quarter. Allianz Asset Management GmbH now owns 27,271 shares of the company’s stock valued at $3,630,000 after acquiring an additional 1,848 shares during the last quarter. DnB Asset Management AS increased its stake in shares of Clorox by 3.8% during the 2nd quarter. DnB Asset Management AS now owns 16,540 shares of the company’s stock valued at $2,237,000 after acquiring an additional 600 shares during the last quarter. IFM Investors Pty Ltd increased its stake in shares of Clorox by 39.3% during the 2nd quarter. IFM Investors Pty Ltd now owns 5,795 shares of the company’s stock valued at $784,000 after acquiring an additional 1,636 shares during the last quarter. Finally, Fisher Asset Management LLC increased its stake in shares of Clorox by 2.1% during the 2nd quarter. Fisher Asset Management LLC now owns 32,473 shares of the company’s stock valued at $4,392,000 after acquiring an additional 662 shares during the last quarter. 78.35% of the stock is owned by hedge funds and other institutional investors.

CLX has been the topic of several recent research reports. Zacks Investment Research upgraded shares of Clorox from a “hold” rating to a “buy” rating and set a $171.00 price objective on the stock in a research report on Wednesday, October 3rd. Deutsche Bank lowered shares of Clorox from a “hold” rating to a “sell” rating and set a $123.00 price objective on the stock. in a research report on Wednesday, October 10th. Argus upgraded shares of Clorox from a “hold” rating to a “buy” rating and set a $175.00 price objective on the stock in a research report on Tuesday, September 25th. UBS Group initiated coverage on shares of Clorox in a research report on Wednesday, July 18th. They issued a “sell” rating and a $110.00 price objective on the stock. Finally, Wells Fargo & Co boosted their price objective on shares of Clorox from $135.00 to $145.00 and gave the stock a “market perform” rating in a research report on Wednesday, October 17th. Four equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and three have assigned a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average target price of $141.64.

COPYRIGHT VIOLATION WARNING: This news story was originally published by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are accessing this news story on another site, it was stolen and republished in violation of United States and international copyright law. The original version of this news story can be read at https://theolympiareport.com/2018/11/11/clorox-co-clx-coo-sells-8531324-95-in-stock.html.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.

Featured Article: Day Trading

Insider Buying and Selling by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.